No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 3, 2010, Pages 328-330

  Piepers, Sanne ^a   Van Den Berg, Leonard H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Olfactory ensheathing cells; Transplantation

Indexed keywords

ADULT; ADVERSE OUTCOME; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DYSPHAGIA; DYSPNEA; FEMALE; FORCED VITAL CAPACITY; HUMAN; MALE; MORTALITY; OLFACTORY ENSHEATHING CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; SPEECH; TREATMENT FAILURE; TREATMENT OUTCOME; WALKING;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; CELL TRANSPLANTATION; FEMALE; FETAL TISSUE TRANSPLANTATION; FETUS; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; OLFACTION DISORDERS; OLFACTORY BULB; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77952185237     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482961003663555     Document Type: Article

References (15)

1. Garbuzova-Davis S, Sanberg PR. Feasibility of cell therapy for amyotrophic lateral sclerosis. Exp Neurol. 2009; 216:3-6.
2. Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm. 2007; 114:1395-406.
3. Ende N, Weinstein F, Chen R, Ende M. Human umbilical cord blood effect on SOD mice (amyotrophic lateral sclerosis). Life Sci. 2000; 67:53-9.
4. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res. 2003; 12:255-70.
5. Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD1 transgenic rats. Transplantation. 2006; 82:865-75.
6. Ibrahim A, Li Y, Li D, Raisman G, el Masry WS. Olfactory ensheathing cells: ripples of an incoming tide? Lancet Neurol. 2006; 5:453-7.
7. Watts J. Controversy in China. Lancet. 2005; 365:109-10.
8. Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005; 128:128-60.
9. Martin LJ, Liu Z. Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice. J Neuropathol Exp Neurol. 2007; 66:1002-18.
10. Morita E, Watanabe Y, Ishimoto M, Nakano T, Kitayama M, Yasui K, et al. A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol. 2008; 213:431-8.
11. Chen L, Huang H, Zhang J, Zhang F, Liu Y, Xi H, et al. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. Zhongguo XiuFu ChongJianWai KeZa Zhi. 2007; 21:961-6.
12. Huang H, Chen L, Xi H, Wang H, Zhang J, Zhang F, et al. Foetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clin Transplant. 2008; 22:710-8.
13. Brooks BR, Miller RG, Swash M, Munsat TL. el Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1:293-9.
14. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci. 2008; 265:78-83.
15. Chew S, Khandji AG, Montes J, Mitsumoto H, Gordon PH. Olfactory ensheathing glia injections in Beijing: misleading patients with ALS. Amyotroph Lateral Scler. 2007; 8:314-6.